Michael Davies

Prof. Dr. Michael Davies

Department of Biomedical Sciences, Building 4.5, Panum Institute, University of Copenhagen, Blegdamsvej 3, Copenhagen 2200, Denmark
orcid

Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 1993 in Clinical Science
Verified
Journal Article
Closed access
NMNicholas J. Miller
Nicholas J. Miller
CRCatherine Rice-Evans
Catherine Rice-Evans
Michael DaviesMichael Davies
Michael Davies
VGVimala Gopinathan
Vimala Gopinathan
AMAnthony Milner
Anthony Milner
1. A new method has been developed for measuring the total antioxidant capacity of body fluids and drug solutions, based on the absorbance of the ABTS*+ radical cation. 2. An automated method for use on a centrifugal analyser, as well as a manual method, is described. 3. The procedure has been applied to physiological antioxidant compounds and radical-scavenging drugs, and an antioxidant ranking was established based on their reactivity relative to a 1.0 mmol/l Trolox standard. 4. The Trolox equivalent antioxidant capacity of plasma from an adult reference population has been measured, and the method optimized and validated. 5. The method has been applied to investigate the total plasma antioxidant capacity of neonates and how this may be compromised in prematurity.

21 February 2022 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
PDF file
HSHelmut Sies
Helmut Sies
VBVsevolod V. Belousov
Vsevolod V. Belousov
NCNavdeep S. Chandel
Navdeep S. Chandel
Michael DaviesMichael Davies
Michael Davies
DJDean P. Jones
Dean P. Jones
CWChristine Winterbourn
Christine Winterbourn

27 June 2022 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
MMMichael P. Murphy
Michael P. Murphy
HBHülya Bayir
Hülya Bayir
VBVsevolod Belousov
Vsevolod Belousov
CCChristopher J. Chang
Christopher J. Chang
KDKelvin J. A. Davies
Kelvin J. A. Davies
BHBarry Halliwell
Barry Halliwell

15 May 1997 in Biochemical Journal
Verified
Journal Article
Open access
PDF file
RDRoger T. Dean
Roger T. Dean
SFShanlin Fu
Shanlin Fu
RSRoland Stocker
Roland Stocker
Michael DaviesMichael Davies
Michael Davies
Radical-mediated damage to proteins may be initiated by electron leakage, metal-ion-dependent reactions and autoxidation of lipids and sugars. The consequent protein oxidation is O2-dependent, and involves several propagating radicals, notably alkoxyl radicals. Its products include several categories of reactive species, and a range of stable products whose chemistry is currently being elucidated. Among the reactive products, protein hydroperoxides can generate further radical fluxes on reaction with transition-metal ions; protein-bound reductants (notably dopa) can reduce transition-metal ions and thereby facilitate their reaction with hydroperoxides; and aldehydes may participate in Schiff-base formation and other reactions. Cells can detoxify some of the reactive species, e.g. by reducing protein hydroperoxides to unreactive hydroxides. Oxidized proteins are often functionally inactive and their unfolding is associated with enhanced susceptibility to proteinases. Thus cells can generally remove oxidized proteins by proteolysis. However, certain oxidized proteins are poorly handled by cells, and together with possible alterations in the rate of production of oxidized proteins, this may contribute to the observed accumulation and damaging actions of oxidized proteins during aging and in pathologies such as diabetes, atherosclerosis and neurodegenerative diseases. Protein oxidation may also sometimes play controlling roles in cellular remodelling and cell growth. Proteins are also key targets in defensive cytolysis and in inflammatory self-damage. The possibility of selective protection against protein oxidation (antioxidation) is raised.

1 January 2005 in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Verified
Journal Article
Closed access
Michael DaviesMichael Davies
Michael Davies

29 March 2016 in Biochemical Journal
Verified
Journal Article
Open access
PDF file
Michael DaviesMichael Davies
Michael Davies
Proteins are major targets for radicals and two-electron oxidants in biological systems due to their abundance and high rate constants for reaction. With highly reactive radicals damage occurs at multiple side-chain and backbone sites. Less reactive species show greater selectivity with regard to the residues targeted and their spatial location. Modification can result in increased side-chain hydrophilicity, side-chain and backbone fragmentation, aggregation via covalent cross-linking or hydrophobic interactions, protein unfolding and altered conformation, altered interactions with biological partners and modified turnover. In the presence of O2, high yields of peroxyl radicals and peroxides (protein peroxidation) are formed; the latter account for up to 70% of the initial oxidant flux. Protein peroxides can oxidize both proteins and other targets. One-electron reduction results in additional radicals and chain reactions with alcohols and carbonyls as major products; the latter are commonly used markers of protein damage. Direct oxidation of cysteine (and less commonly) methionine residues is a major reaction; this is typically faster than with H2O2, and results in altered protein activity and function. Unlike H2O2, which is rapidly removed by protective enzymes, protein peroxides are only slowly removed, and catabolism is a major fate. Although turnover of modified proteins by proteasomal and lysosomal enzymes, and other proteases (e.g. mitochondrial Lon), can be efficient, protein hydroperoxides inhibit these pathways and this may contribute to the accumulation of modified proteins in cells. Available evidence supports an association between protein oxidation and multiple human pathologies, but whether this link is causal remains to be established.